“…In breast tumors, four subset of CAFs were captured in MMTV‐PyMT tumors, namely vascular CAFs (vCAF), matrix CAFs (mCAF), cycling CAFs (cCAF), and developmental CAFs (dCAF), representing a perivascular origin (vCAF and cCAF), a resident fibroblast origin (mCAF), and an EMT origin (dCAF) . In pancreatic cancer in contrast to normal pancreas, distinct CAFs subpopulations include a population associated with insulin‐like growth factor signaling (FB1), a population expressing Ly6a/c1 (lymphocyte antigen complex locus and locus c1) and Pi16 (peptidase inhibitor 16) (FB2), and a population with mesothelial markers, including Msln (mesothelin), and Cav1 , Cdh11 (cadherin 11), and Gas6 (growth arrest‐specific 6) (FB3) . Interestingly, only FB1 and FB3 persisted in pancreatic ductal adenocarcinoma (PDAC), with FB2 cells merging toward an FB1 transcriptome, and FB3 contain Acta2 + myofibroblasts as well as MHCII + cells, suggesting an immune modulatory function.…”